View in EDS

Comparing serotype coverage of pneumococcal vaccines with PCV21 (V116), a new 21-valent conjugate pneumococcal vaccine, and the epidemiology of its eight unique Streptococcus pneumoniae serotypes (15A, 15C, 16F, 23A, 23B, 24F, 31 and 35B) causing invasive pneumococcal disease in adult patients in Canada: SAVE study, 2018–21 Open Access

Saved in:
Bibliographic Details
Title: Comparing serotype coverage of pneumococcal vaccines with PCV21 (V116), a new 21-valent conjugate pneumococcal vaccine, and the epidemiology of its eight unique Streptococcus pneumoniae serotypes (15A, 15C, 16F, 23A, 23B, 24F, 31 and 35B) causing invasive pneumococcal disease in adult patients in Canada: SAVE study, 2018–21 Open Access
Authors: Schellenberg, John J1 (AUTHOR), Adam, Heather J1,2 (AUTHOR), Baxter, Melanie R1 (AUTHOR), Karlowsky, James A1,2 (AUTHOR), Golden, Alyssa R3 (AUTHOR), Martin, Irene3 (AUTHOR), Zhanel, George G1 (AUTHOR)
Source: Journal of Antimicrobial Chemotherapy (JAC). May2025, Vol. 80 Issue 5, p1377-1385. 9p.
Database: Environment Complete
Description
ISSN:03057453
DOI:10.1093/jac/dkaf085